MicroVue™ YKL-40 EIA

The MicroVue YKL-40 is a test to measure YKL-40, also known as human cartilage 39 (HC gp-39), in serum and human cell cultures.


Product Specifications

Citations0
Specimen

Serum/EDTAPlasma 20 μL

LLOQN/A
ULOQN/A
Assay Time3 hours
Cross Reactivity

Baboon, Cynomolgous monkey, Rhesus monkey

Ordering Information

For Research Use Only. Not for use in diagnostic procedures.
Catalog Number8020
Catalog Number (CE) 
Size96 wells/test
Price (USD)$970.00
Price (EURO)680,00 €

Contact us

US Phone+1 (858) 552 1100
EU Phone+353 (91) 412 474
US Emailcontact-us@quidelortho.com
EU Emailcontact-emea@quidelortho.com

Specifications

Description

The MicroVue YKL-40 is a test to measure YKL-40, also known as human cartilage 39 (HC gp-39), in serum and human cell cultures.

Size96 wells/test
Form

96 well plate with 12 eight-well strips in a resealable foil pouch

SpecimenSerum/EDTAPlasma 20 μL
Limit of Detection (LOD)5.4 ng/mL
Lower Limit of Quantitation (LLOQ)N/A
Upper Limit of Quantitation (ULOQ)N/A
Intra Assay5.6-6.6%
Inter Assay6.0-7.0%
Standards6
Controls2
Sample Values

Adult (EDTA Plasma) 20-130 ng/mL, Females (Serum) 25-93 ng/mL, Males (Serum) 24-125 ng/mL

Assay Time3 hours
Cross Reactivity

Baboon, Cynomolgous monkey, Rhesus monkey

Storage

Store unopened kit between 2°C to 8°C. Refer to manual for storing individual components

Background

YKL-40 — also known as human cartilage glycoprotein 39 (HC gp-39) is a 40 KD glycoprotein first described in whey secretions of nonlactating cows. Subsequently, its production by chondrocytes, synovial cells, activated macrophages, neutrophils, and osteosarcoma cells (MG-63) has been reported. It has both heparin and chitin binding domains and appears to be an autoantigen in rheumatoid arthritis. Early studies suggest YKL-40 is useful for researching:Rheumatoid Arthritis, Early polyarthritis, Osteoarthritis, Giant cell arteritis, Liver fibrosis, Breast cancer, Colorectal cancer. Recently, serum YKL-40 has been investigated as a new marker for cancer. Elevated serum YKL-40 is associated in many cancers studied to date, including cancer of the colon, lung, prostate, ovary, and breast.

Citations

TitleYearApplicationsSample SpeciesSampleSample Details